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JCDR Editorial
Preface to the Journal of Cardiovascular Disease Research, 
second issue 2012
I am delighted to present this issue of the Journal of 
Cardiovascular Disease Research (JCDR). The JCDR is 
proud to enter 2012 in a strong position. Readers may 
be aware that Wolters Kluwer Health (Philadelphia, 
PA) acquired Medknow and thus became the publisher 
of JCDR. Wolters Kluwer Health is a leading global 
provider of information and business intelligence for 
physicians, nurses, students and specialized clinicians. 
Major brands include Lippincott Williams & Wilkins, 
Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, 
Pharmacy OneSource® and ProVation® Medical. With 
new opportunities and challenges, we will continue to 
strive to make JCDR more influential, powerful and useful 
to the cardiovascular disease research community. The 
exponential growth and enhanced visibility of JCDR is 
reflected by the rapid rate of indexing in PubMed, PubMed 
Central, Scopus, Google Scholar, Chemical Abstracts, etc. 
This is paralleled by an increase in the number of article 
downloads, indicating that JCDR has been attracting more 
readers in the area of cardiovascular disease research. The 
number of submitted manuscripts from all over the world 
is also increasing steadily, demonstrating that our journal 
is becoming a respected and reliable venue for researchers 
to disseminate their findings.
I would like to take this opportunity to welcome our 
new associate editors and section editors and thank our 
hard-working reviewers and editorial board members for 
their dedicated service to this scientific endeavor, to our 
authors and readers for their contributions and continued 
interest in JCDR, and to our publisher for their effort to 
expand the influence and quality of JCDR. We still have 
a long road ahead of us, and as always we welcome your 
new ideas, valuable comments, suggestions and feedback. 
Through your involvement, we are closer to accomplishing 
our goal of positioning JCDR among the leading journals 
in the field of cardiovascular disease.
MEMBERS IN THE NEWS
On behalf of the JCDR editorial board, I would like to 
congratulate the Editor-in-Chief of JCDR, Dr. Peng Zhou, 
on his appointment as Chairman of the Education/CME 
Committee of the Chinese American Heart Association. 
We applaud this achievement and extend our warm wishes 
for continued success. In addition, because JCDR has been 
receiving more clinical manuscripts, Yongxia Sarah Qu MD, 
PhD, and Guangzhen Zhong MD, PhD, were appointed 
as Associate Editors of JCDR.
LAUNCH OF NEW SECTIONS OF JCDR
Last year we launched the Section of Cardiothoracic Surgery, 
an endeavor spearheaded by Vakhtang Tchantchaleishvili, 
MD, Department of Surgery, University of Rochester 
Medical Center. Dr. Tchantchaleishvili has authored several 
publications and book chapters in cardiac surgery although 
his main interest includes various treatment modalities for 
heart failure. The Section of Cardiothoracic Surgery has 
continued to evolve since its introduction in the 3rd issue 
of 2011. As a consequence, we have decided to establish 
additional sections in sub-areas of cardiovascular disease 
research and invite internationally recognized experts as 
section editors.
Commissioned by Dr. Peng Zhou (Editor-in-Chief, JCDR), 
I am thus pleased to officially announce, on behalf of the 
JCDR editorial board, the launch of the following sections 
of JCDR: Dayue Darrel Duan, MD, PhD, FAHA, will 
serve as the Section Editor of Frontiers in Cardiovascular 
Research; John F. Beshai, MD, FACC, FHRS, will serve as 
the Section Editor of Clinical Electrophysiology; Li Zhang, 
MD, will serve as the Section Editor of Continuing Medical 
Education; while Cynthia C. Taub, MD, FACC, FASE, 
will supervise the Section of Non-invasive Cardiology; 
Pitchai Balakumar, PhD, will serve as the Section Editor 
of Cardiovascular Pharmacology.
Dr. Dayue Darrel Duan is a Professor at the Department of 
Pharmacology, University of Nevada School of Medicine. 
He is an internationally renowned cardiovascular scientist. 
He is President-elect of the Academy of Cardiovascular 
Research Excellence. Dr. Duan has served on numerous 
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boards and expert committees, including the U.S. National 
Institutes of Health (NIH) Center for Scientific Review 
Special Emphasis Panel (NHLBI Systems Biology), 
American Institute of Biological Sciences NYSTEM 
Cardiology Panel, Biotechnology and Biological Sciences 
Research Council of UK, Canadian Institutes of Health 
Research, Peer Review and Research Committees in 
American Heart Association, Life Science Committee 
at the National Natural Science Foundation of China, 
Expert Committee for the Ministry of Education of 
China, The Research Grants Council of Hong Kong, 
Executive Committee and Chairman of Award Committee 
in Division of Cardiovascular Pharmacology of American 
Society of Pharmacology and Experimental Therapeutics. 
He has published extensively in prestigious journals such 
as Nature, Circulation, and Circulation Research. Dr. 
Duan serves on the editorial boards of several leading 
international cardiovascular and pharmacological journals 
and reviewer for 56 peer-reviewed scientific journals. His 
research has been continuously supported by NIH and 
American Heart Association. Dr. Duan’s research interests 
include ion channels, functional genomics and proteomics, 
phenomics, cardiac electrophysiology and pharmacology, 
cardiac ischemia, cardioprotection, myocardial hypertrophy 
and heart failure.
Dr. John F. Beshai, an Associate Professor of Medicine 
at the University of Chicago, has earned a reputation as 
an international expert in cardiac electrophysiology. He 
is an Associate Director of the Heart Rhythm Center 
and the Director of Pacemaker/Defibrillator Services. 
His clinical expertise includes radiofrequency catheter 
ablation for atrial fibrillation, ventricular tachycardia and 
supraventricular tachycardia, as well as pacemaker and 
defibrillator implantation for cardiac arrhythmia. As a 
respected scientist, Dr. Beshai’s clinical research interests 
are focused on device therapy in patients with congestive 
heart failure and sarcoidosis. In addition, he is involved 
in multiple studies developing new technologies and 
approaches to radiofrequency catheter ablation of complex 
arrhythmias, including atrial fibrillation and ventricular 
tachycardia. Dr. Beshai served as the national principal 
investigator and Steering Committee Chairman for the 
Cardiac Resynchronization Therapy in Heart Failure and 
Narrow QRS complexes (RETHINQ) trial, and was senior 
author of its publication in the New England Journal of 
Medicine.
Dr. Li Zhang is an Associate Professor at Jefferson Medical 
College and Lankenau Institute for Medical Research. She 
is the Director of Cardiovascular Outcomes Research 
of Main Line Health Heart Center at Lakenau Institute 
for Medical Research. Dr. Zhang is a renowned expert in 
inherited arrhythmias associated with increased risks of 
sudden death in young but otherwise healthy individuals. 
Dr. Zhang’s primary research goal is to improve the early 
diagnosis of fatal cardiac arrhythmia for prompt medical 
intervention and sudden death prevention. Her publication 
record is prolific. She has made important contributions in 
establishing the ongoing registry studies in China for long 
QT syndrome (LQTS), arrhythmogenic right ventricular 
dysplasia (ARVD) and left ventricular noncompaction. 
Dr. Zhang is Vice President of the Chinese American 
Heart Association. She is also an Adjunct Professor at 
Xi’an Jiaotong University and Guest Professor at Peking 
University.
Dr. Cynthia C. Taub is an Associate Professor of Clinical 
Medicine at Albert Einstein College of Medicine, and 
the Director of Non-invasive Cardiology at Einstein 
Division/Montefiore Medical Center. Dr. Taub serves on 
the FASE Committee at the American Society of Echo. 
She is also on the Executive and Medical Leadership 
Committee for the American Heart Association “Go 
Red” campaign. Dr. Taub is Vice President of the Chinese 
American Heart Association. She has received numerous 
teaching and research awards. She is well-known for her 
expertise in tissue Doppler imaging, 3D echocardiography, 
echocardiographic evaluation of cardiac resynchronization 
therapy, intraoperative transesophageal echocardiography 
and adult congenital heart disease.
Dr. Pitchai Balakumar is a Professor and Head of 
Department of Pharmacology at Rajendra Institute 
of Technology and Sciences, Sirsa, Haryana, India. 
He is the Editor-in-Chief of the Current Research in 
Cardiovascular Pharmacology and the Associate Editor 
for the International Journal of Recent Advances in 
Pharmaceutical Research. He was a Guest Editor of 
the Pharmacological Research (Elsevier Journal) for 
the Special Issue on peroxisome proliferator activated 
receptors (PPARs) in 2009 and a Guest Editor of the 
Current Molecular Pharmacology (Bentham Science 
Journal) for the Special Issue on PPARs in 2011. Dr. 
Balakumar has been widely recognized in cardiac 
hypertrophy and heart failure, myocardial ischemia-
reperfusion injury, myocardial preconditioning and 
postconditioning, vascular endothelial physiology and 
pathophysiology.
THIS ISSUE OF JCDR
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disease. I hope that JCDR readers find this issue interesting 
and informative. Below I highlight several key findings of 
some reports.
In an interesting study addressing the issue of genotype-
phenotype analysis, Gao et al. explored the causes and 
clinical implications of Jervell and Lange-Nielsen syndrome 
(JLNS) in Chinese patients. JLNS is a rare form of LQTS 
with congenital sensorineural deafness. They identified 
seven KCNQ1 mutations, including two novel mutations 
that cause JLNS. Some identified mutations have been 
previously described in patients with Romano-Ward 
syndrome (RWS). They also found that ECG abnormalities 
in JLNS patients were associated with their clinical 
symptoms. They concluded that compound heterozygous 
KCNQ1 mutations could result in both JLNS and severe 
forms of RWS in Chinese patients. This study expanded 
the mutation and phenotype spectrum of JLNS and 
provided valuable information for our understanding of 
LQTS and JLNS.
In an article from Denmark, Thim et al. used novel surgical 
techniques along with medical and imaging techniques to 
investigate the relationship between wall shear stress and 
local plaque development in stenosed carotid arteries of 
hypercholesterolemic minipigs. Atherosclerotic lesions, 
in pre- and post-stenotic segments, were associated with 
thrombus in the stenosed segment. In patent carotid 
arteries, atherosclerotic lesions were only found in the 
post-stenotic segments. It was concluded that both low 
and oscillatory shear stress together would advance the 
development of atherosclerotic plaques with necrotic cores. 
This study has clinical significance in our understanding of 
the development of atherosclerotic plaques.
Chu et al. examined the association between the G-308 A 
(rs1800629) polymorphism of the tumor necrosis factor-
alpha (TNF-α) gene and risk of coronary artery disease 
(CAD) and myocardial infarction (MI) in the Chinese Han 
population. The authors determined the genotypes of 
TNF-α G-308A (rs1800629) in Chinese patients with CAD, 
MI and controls. They also performed a meta-analysis of 
all previous studies on TNF-α G-308A polymorphism 
and the risk of CAD and MI. They concluded that there 
was no association between the G-308 A (rs1800629) 
polymorphism of the TNF-α gene (presence of A allele) 
and CAD/MI.
The global increase in patients with chronic kidney disease 
(CKD) is threatening to reach epidemic proportions over 
the next decade. Muhaisen et al. investigated the association 
between various risk factors of cardiovascular disease 
and different stages of CKD in children without kidney 
replacement therapy in the Gaza strip. The findings of this 
study indicate that many cardiovascular disease risk factors 
are associated with different stages of CKD in children 
prior to dialysis and some of these factors are exacerbated 
as CKD progresses. This study has potential implications 
in monitoring the progress of the disease and predicting 
future outcomes of CKD patients.
Petroleum products have been reported as environmental 
health risk factors that are associated with cardiovascular 
morbidity and mortality. Azeez et al. described the effects 
on body weight gain and cardiovascular function in a rat 
model. The results showed that exposure to petroleum 
products is associated with increased systolic blood 
pressure, diastolic blood pressure, mean arterial pressures, 
heart rate, and reduced body weight. A potential mechanism 
is that inhalation of petroleum products is associated with 
baroreflex sensitivity and arterial blood pressure resetting.
Family history has been shown to be a risk factor for 
many chronic diseases. Das et al. analyzed the association 
between the family history of type 2 diabetes mellitus 
(T2DM) and the risk of developing metabolic syndrome 
(MS) in the Indian population. The authors concluded 
that family history of T2DM was a significant predictor 
for the risk of MS. This study provides useful information 
in the prevention and early diagnosis of MS.
In a rare case study, Mohite et al. presented an interesting 
case of a ruptured aneurysm of the right sinus of Valsalva 
into the main pulmonary artery, resulting in congestive 
heart failure. Very few similar cases have been reported. 
The authors detected the defect by trans-thoracic and trans-
esophageal echo as well as angiogram. To my knowledge, 
this is the most extensive evaluation of such a case.
In another case study, Mohite et al. presented an unusual 
case of a 2-year-old child with obstruction of the superior 
vena cava after open-heart surgery. The cause of the 
obstruction was a tight closure of the pericardium overlying 
the vena cava. It provides new insight into the clinical 
management of such patients.
To better understand thrombocytopenia, Patnaik et al. 
presented an uncommon case of fatal thrombocytopenia 
that were associated with intracardiac tumor. The authors 
provided useful clinical results with a potential diagnosis 
on such patients. They discussed the potential causes of 
thrombocytopenia. Also included with this case report is 
an accompanying editorial from Dr. Kan Chen of Brigham 
and Women’s Hospital and Harvard Medical School in 
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Cao et al. described an atypical case of an inferior myocardial 
infarction secondary to aortic dissection associated with 
bicuspid aortic valve. The 40-year-old female patient was 
given anticoagulation and antiplatelet treatment. Surgical 
treatments included successful replacement of the 
ascending aorta, aortic valve replacement and coronary 
artery bypass grafting. This work adds significantly to our 
understanding on how such patients should be diagnosed 
and managed.
Generalized arterial calcification of infancy (GACI) is a 
rare, fatal, autosomal-recessive disease. GACI is associated 
with a high mortality rate owing to the development of 
severe hypertension and cardiovascular complications in 
early infancy. Kalal et al. provided a detailed report of a case 
of GACI and recommended that along with investigations 
like CT and fetal echo scan, molecular analysis of 
ectonucleotide pyrophosphatase/phosphodiesterase 1 
(ENPP1) should be included in the clinical diagnosis of 
GACI.
Ventricular septal defect (VSD) complicating acute 
myocardial infarction is a very serious medical condition, 
which further deteriorates hemodynamics. Patnaik et al. 
provided a successful therapy to an anterior myocardial 
infarction patient with VSD, which is helpful to other 
health care providers in making a strategic clinical 
decision.
Kota et al. reported a case of a 48-year-old patient 
with pheochromocytoma and inferior vena cava (IVC) 
thrombosis. Pheochromocytoma with IVC thrombosis is 
a rare clinical condition. The authors described the results 
of abdominal CT and IVC venogram, and discussed 
the criteria for diagnosis and therapy. Surgical removal 
of pheochromocytoma was followed by anticoagulant 
treatment for IVC thrombosis.
In a case study, Jagiasi et al. reported a 38-year-old 
patient diagnosed with coronary vasospasm. The authors 
provided helpful information to clinicians by advising that 
coronary vasospasm should be considered in the setting 
of chest pain at rest with ST-T changes and localized 
stenosis on coronary angiography in the absence of 
obvious thrombosis, which might prevent unnecessary 
coronary stenting.
In the case of a 48-year-old patient with thrombotic 
thrombocytopenic purpura (TTP), Atreya et al. reported 
a rare case where TTP was manifested by ST-segment 
elevation myocardial infarction. It highlights the significance 
of a comprehensive clinical examination and may benefit 
future cases with similar characteristics.
In other clinical case reports: Oyedeji et al. presented a case 
of cor triatriatum sinistrum coexisting with a prominent 
Eustachian valve in which the diagnosis was confirmed 
by two-dimensional transthoracic echocardiography. 
Barik et al. reported a case in which congenital bicuspid 
aortic valve, aortic regurgitation, aortic coarctation and 
ruptured sinus of Valsalva aneurysm were surgically 
repaired in a single-stage procedure. Aundhakar et al. 
described the characteristics of cardiorenal syndrome 
(CRS) and the diagnosis of a patient with CRS who was 
resistant to diuretics and sensitive to ultrafiltration. Thej 
et al. reported a case with myocardial bridging over the 
left anterior descending artery combined with obstructive 
atherosclerosis in the proximal and intramyocardial part. 
Sakaria et al. described a case of Lutembacher syndrome in a 
22-year-old pregnant lady, including a detailed examination 
and clinical investigation of the patient.
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